BRUSSELS – BUDAPEST – FLORENCE – LISBON – MADRID – MILAN – NEW YORK PARIS – PHILADELPHIA – PRAGUE – ROME – SOFIA – VIENNA - VILNIUS New Potential Sponsorship Strategies for Cardiovascular Societies Stefano Remiddi, AIM Group Int.l Strategic Consultant Hungarian Society of Hypertension Siòfok, September 27th, 2014

Big Pharma: a new growing period is coming !

But… Therapeutic Areas will be different

Driven by Big Giants only September 1st, 2014: NOVARTIS announces outstanding study results for LCZ696, a new agent against Hear Failure. NOVARTIS shares rose +5% in the following 3 days (business potential estimated = 6 Bil. $ on annual basis). September 4th, 2014: FDA grants accelerated approval for KEYTRUDA, a new Merck drug against Melanoma, first of a new class of agents (PD-1 Inhibitors). Expected price per Patient = USD. For the first six months in 2014, SOVALDI, the new Gilead breakthrough therapy for Hepatitis C, achieved worlwide sales of 5.8 Bil. $ (price per Patient = €).

Top 10 Pharma Companies in 2013 CompanySales (USD Bill.) R&D Spend (USD MilL.) R&D (%) 1. PFIZER (NY, US) , NOVARTIS (Basel, CH) * , MERCK (NJ, US) , SANOFI (Paris, FR) * , ROCHE (Basel, CH) , GLAXOSMITHKLINE (UK) , ASTRAZENECA (UK) , JOHNSON&JOHNSON (NJ, US) , ABBOTT (IL, US) , ELI LILLY (IN, US) , Source: Pharmaceutical Executive 2013 (*) Companies with new breaktrough CV products in R&D

BRUSSELS – BUDAPEST – FLORENCE – LISBON – MADRID – MILAN – NEW YORK PARIS – PHILADELPHIA – PRAGUE – ROME – SOFIA – VIENNA - VILNIUS Key Considerations  Sponsorship opportunities for Pharma Companies at the events of the Cardiovascular Societies are constantly declining  Young Fellows and other Specialists are less represented in the International Congresses  Number of Countries represented at the International Congresses is reducing over time  Pharma Industry Sponsorship will be further reduced because of the lack on new CV (AntiHT) Agents  There is the need to find new avenues preserving the Scientific Core of CV Scientific Societies but trying to expand a little bit the range of activities towards new directions to grow

BRUSSELS – BUDAPEST – FLORENCE – LISBON – MADRID – MILAN – NEW YORK PARIS – PHILADELPHIA – PRAGUE – ROME – SOFIA – VIENNA - VILNIUS First Step: Line Extension

BRUSSELS – BUDAPEST – FLORENCE – LISBON – MADRID – MILAN – NEW YORK PARIS – PHILADELPHIA – PRAGUE – ROME – SOFIA – VIENNA - VILNIUS Line Extension of Current Key Topics: Medical Devices

BRUSSELS – BUDAPEST – FLORENCE – LISBON – MADRID – MILAN – NEW YORK PARIS – PHILADELPHIA – PRAGUE – ROME – SOFIA – VIENNA - VILNIUS Digital Revolution in Health Care is expected to mobilize high investments with a significant shift to Home Care Assistance

BRUSSELS – BUDAPEST – FLORENCE – LISBON – MADRID – MILAN – NEW YORK PARIS – PHILADELPHIA – PRAGUE – ROME – SOFIA – VIENNA - VILNIUS Potential Key Digital Players/Sponsor in Europe

BRUSSELS – BUDAPEST – FLORENCE – LISBON – MADRID – MILAN – NEW YORK PARIS – PHILADELPHIA – PRAGUE – ROME – SOFIA – VIENNA - VILNIUS Line Extension of Current Key Topics: Diagnostics & Genetics

BRUSSELS – BUDAPEST – FLORENCE – LISBON – MADRID – MILAN – NEW YORK PARIS – PHILADELPHIA – PRAGUE – ROME – SOFIA – VIENNA - VILNIUS Line Extension of Current Key Topics: Life Style Changes

BRUSSELS – BUDAPEST – FLORENCE – LISBON – MADRID – MILAN – NEW YORK PARIS – PHILADELPHIA – PRAGUE – ROME – SOFIA – VIENNA - VILNIUS Second Step: Technology Integration

Web Marketing e Dematerializzazione Web Marketing & Dematerialization

Web Marketing: Impact on Physician activity

EU Commission: Green Paper on Mobile Health

DataN. App disponibiliN. Download 11 Luglio Settembre Milioni 4 Novembre Miliardi 4 Ottobre Miliardi 16 Maggio Miliardi APP proposito… ma quante “App” esistono ?... Application for the future

Studio Consulenziale Dr. S.Remiddi The new Targets: Patient Communities

Web Marketing: Social Media & Gamification

Web Site & Web Engagement Visual patterns observed during a web site navigation: performance of the customer engagement related with e-commerce activity “Eye Gaze Patterns while Searching vs. Browsing a Website“ Sav Shrestha e Kelsi Lenz, Usability News,2007Eye Gaze Patterns while Searching vs. Browsing a Website

BRUSSELS – BUDAPEST – FLORENCE – LISBON – MADRID – MILAN – NEW YORK PARIS – PHILADELPHIA – PRAGUE – ROME – SOFIA – VIENNA - VILNIUS Third Step: Range Expansion

BRUSSELS – BUDAPEST – FLORENCE – LISBON – MADRID – MILAN – NEW YORK PARIS – PHILADELPHIA – PRAGUE – ROME – SOFIA – VIENNA - VILNIUS Expansion of Current Horizon High Blood PressureOrgan DamagePrevention Interest

BRUSSELS – BUDAPEST – FLORENCE – LISBON – MADRID – MILAN – NEW YORK PARIS – PHILADELPHIA – PRAGUE – ROME – SOFIA – VIENNA - VILNIUS Expansion of Current Horizon: Prevention  Life Style Changes  Food  Diet  Ionic-Metabolic Balance  Nutraceuticals  Sports & Wellness  QoL  HT Prevention Guidelines

BRUSSELS – BUDAPEST – FLORENCE – LISBON – MADRID – MILAN – NEW YORK PARIS – PHILADELPHIA – PRAGUE – ROME – SOFIA – VIENNA - VILNIUS Nutraceuticals

BRUSSELS – BUDAPEST – FLORENCE – LISBON – MADRID – MILAN – NEW YORK PARIS – PHILADELPHIA – PRAGUE – ROME – SOFIA – VIENNA - VILNIUS Conclusions & Suggested Actions  Develop a platform Strategy to sinergy the Technology Integration and remain highly attractive for potential Sponsors in this new area  Design Web Site, Web Marketing Activities and Integrate all Communication Channels including Social Network Strategy for Patient Communities  Be ready to create the necessary spaces at each Congress (scientific arena & commercial/sponsorship arena)  Interact with other key stakeholders in the new areas (eg European Association of Nutraceuticals, Sports & Medicine, Dietology Associations)

Thanks for your attention !